StonvexLoading…
StonvexStonvexStonvexCore line items from NEOV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $13.32M | $11.30M | $6.65M | $8.43M |
Operating Income | $-7.96M | $-5.33M | $-854.33K | $-4.72M |
Net Income | $-9.81M | $-5.54M | $-1.24M | $-5.03M |
EPS (Diluted) | $-0.27 | $-0.20 | $-0.04 | $-0.15 |
Total Assets | $25.66M | $10.11M | $8.45M | $6.81M |
Total Liabilities | $3.48M | $5.11M | $6.31M | $3.90M |
Cash & Equivalents | $11.48M | $242.43K | $889.82K | $794.84K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 42.71M | 36.20M | 34.21M | 34.12M |